or Try an Advanced Search...

    Technical Analysis for BMRA - Biomerica, Inc.

    Grade Last Price % Change Price Change
    F 0.63 -2.64% -0.02
    BMRA closed down 2.64 percent on Friday, May 24, 2024, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BMRA trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Pocket Pivot Bullish Swing Setup -2.64%
    NR7 Range Contraction -2.64%
    Narrow Range Bar Range Contraction -2.64%
    Overbought Stochastic Strength -2.64%
    Down 3 Days in a Row Weakness -1.11%
    Gapped Down Weakness -1.11%
    Older End-of-Day Signals for BMRA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 3 days ago
    Up 1% 3 days ago
    Possible NR7 3 days ago
    10 DMA Support 3 days ago
    Down 2 % 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BMRA Chart by TradingView
    Basic chart:

    Profile

    BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Biotechnology Pharmaceutical Pharmacy Clinic Pharmacology Diagnostic Products Human Diseases Medical Diagnostic Medical Diagnostic Products

    Is BMRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 29 Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company
    Apr 29 Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
    Apr 15 Biomerica provides update on inFoods® IBS expansion
    Apr 15 Biomerica GAAP EPS of -$0.11, revenue of $1M
    Apr 12 Biomerica Reports Third Quarter 2024 Financial Results
    Feb 21 Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
    Jan 16 Biomerica reports Q2 results
    Jan 16 Biomerica Reports Second Quarter 2024 Financial Results
    Dec 20 Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?
    Dec 19 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    See more BMRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.13
    52 Week Low 0.5
    Average Volume 281,022
    200-Day Moving Average 0.95
    50-Day Moving Average 0.75
    20-Day Moving Average 0.61
    10-Day Moving Average 0.63
    Average True Range 0.06
    RSI (14) 43.50
    ADX 33.56
    +DI 12.88
    -DI 20.79
    Chandelier Exit (Long, 3 ATRs) 0.60
    Chandelier Exit (Short, 3 ATRs) 0.68
    Upper Bollinger Bands 0.68
    Lower Bollinger Band 0.54
    Percent B (%b) 0.63
    BandWidth 21.78
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0148
    Fundamentals Value
    Market Cap 10.53 Million
    Num Shares 16.8 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -1.65
    Price-to-Sales 2.84
    Price-to-Book 1.66
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.67
    Resistance 3 (R3) 0.67 0.66 0.66
    Resistance 2 (R2) 0.66 0.65 0.66 0.66
    Resistance 1 (R1) 0.65 0.65 0.64 0.64 0.66
    Pivot Point 0.64 0.64 0.63 0.63 0.64
    Support 1 (S1) 0.62 0.62 0.61 0.61 0.59
    Support 2 (S2) 0.61 0.62 0.60 0.59
    Support 3 (S3) 0.59 0.61 0.59
    Support 4 (S4) 0.58